Glofitamab (Anti-CD20 & CD3)
Product Specifications
CAS Number
2229047-91-8
Synonyms
RG6026, RO7082859
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Glofitamab is a T-cell–engaging bispecific antibody that targets CD3 and CD20, demonstrating significant antitumor activity and durable responses in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) . It works by binding to CD20 on B cells and CD3 on T cells, promoting T-cell-mediated lysis of malignant B cells. MW: 170.28 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882200-500 1x 500 µL
Cytokeratin 7 (Glandular and Transitional Epithelial Marker) (KRT7/2200), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
RD-TREM1-Mu-01 96 Tests
Mouse Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ELISA Kit
Sign In for Pricing
View Details